Current perspectives on radiation-induced breast cancer

Journal of Clinical Oncology

Volumn 16, Issue 1, 1998, Pages 338-347

  Goss, Paul E ^a   Sierra, Sony ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ATOMIC BOMB; BREAST CARCINOMA; CANCER EPIDEMIOLOGY; CANCER RISK; CANCER SCREENING; CHROMOSOME 17Q; CLINICAL EXAMINATION; GENETIC SUSCEPTIBILITY; HODGKIN DISEASE; HUMAN; MAMMOGRAPHY; MASTECTOMY; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; RADIATION CARCINOGENESIS; RADIATION EXPOSURE; REVIEW; SELF EXAMINATION;

EID: 0031972611     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.1.338     Document Type: Review

References (85)

1. McCann J, Dietrich F, Rafferty C: A critical review of the genotoxic potential of electric and magnetic fields. Mutat Res 297:61-95, 1993
2. Salvatore JR, Blackinton D, Polk C, et al: Non-ionizing electromagnetic radiation: A study of carcinogenic and cancer treatment potential. Rev Environ Health 10:197-207, 1994
3. th GHA Clowes Memorial Lecture. Cancer Res 48:4135-4143, 1988
4. Rauth AM: Radiation carcinogenesis, in Tannock IF, Hill RP (eds): Basic Science of Oncology (ed 2). New York, NY, McGraw Hill, 1992, pp 119-135
5. Guerrero I, Villasante A, Corces V, et al: Activation of a c-K-ras oncogene by somatic mutation in mouse lymphomas induced by gamma radiation. Science 225:1159-1169, 1984
6. Modrich P: DNA mismatch correction. Ann Rev Biochem 56:435-466, 1987
7. Cox R: Molecular mechanisms of radiation oncogenesis. Int J Radiat Biol 65:57-64, 1994
8. Storer JB: Radiation Carcinogenesis, in Becker FF (ed): Cancer: A Comprehensive Treatise (ed 2). New York, NY, Plenum, 1982, pp 629-659
9. Varley JM, Armour J, Swallow JE, et al: The retinoblastoma gene is frequently altered leading to loss of expression in primary breast tumours. Oncogene 4:725-729, 1989
10. Fung Y, Ang A: The role of the retinoblastoma gene in breast cancer development. Cancer Treat Res 61:59-68, 1992
11. Tokunaga M, Land CE, Tokuoka S, et al: Incidence of female breast cancer among atomic bomb survivors, 1950-1985. Radiat Res 138:209-223, 1994
12. Wang J, Inskip PD, Boice JDJ: Cancer incidence among medical diagnostic x-ray workers in China, 1950 to 1985. Int J Cancer 45:889-895, 1990
13. Vaughan TL, Lee JA, Strader CH: Breast cancer incidence of a nuclear facility: Demonstration of a morbidity surveillance system. Health Phys 64:349-354, 1993
14. Pukkala E, Auvinen A, Wahberg G: Incidence of cancer among Finnish airline cabin attendants, 1967-1992. Br Med J 311:649-952, 1995
15. Boice JDJ, Mandel JS, Doody MM: Breast cancer among radiologie technologists. JAMA 274:394-401, 1995
16. Furst CJ, Lundell M, Holm L: Cancer incidence after radiotherapy for skin hemangioma: A retrospective cohort study in Sweden. J Natl Cancer Inst 80:1387-1392, 1988
17. Lundell M, Holm LE: Risk of solid tumors after irradia tion in infancy. Acta Oncol 34:727-734, 1995
18. Lundell M, Mattsson A, Hakulinen T, et al: Breast cancer after radiotherapy for skin hemangioma in infancy. Radiat Res 145:225-230, 1996
19. Modan B, Chetrit A, Alfandary E: Increased risk of breast cancer after low-dose irradiation. Lancet 1:629-631, 1989
20. Hildreth NG, Shore RE, Dvoretsky PM: The risk of breast cancer after irradiation of the thymus in infancy. N Engl J Med 321:1281-1284, 1989
21. Jhaveri R, Brief DK, Schweitzer V: Breast cancer after radiation exposure in childhood. NJ Med 90:234-236, 1993
22. Myrden JA, Hiltz JE: Breast cancer following multiple fluoroscopies during artificial pneumothorax treatment of pulmonary tuberculosis. Can Med Assoc J 100:1032-1034, 1962
23. Miller AB, Howe GB, Shennan GJ: Mortality from breast cancer after irradiation during fluoroscopic examinations in patients being treated for tuberculosis. N Engl J Med 321:1285-1289, 1989
24. Boice JD, Monson RR: Breast cancer in women after repeated fluoroscopic examinations of the chest. J Natl Cancer Inst 59:823-832, 1977
25. Hrubec Z, Boice JDJ, Monson RR: Breast cancer after multiple chest fluoroscopies: Second followup of Massachusetts women with tuberculosis. Cancer Res 49:229-234, 1989
26. Boice JDJ, Preston D, Davis FG, et al: Frequency chest x-ray fluoroscopy and breast cancer incidence among tuberculosis patients in Massachusetts. Radiat Res 125:214-222, 1991
27. Baral E, Larsson L, Mattsson B: Breast cancer following irradiation of the breast. Cancer 55:179-190, 1977
28. Mattsson A, Ruden BI, Hall P, et al: Radiation-induced breast cancer: Long-term follow-up of radiation therapy for benign breast disease. J Natl Cancer Inst 85:1679-1685, 1993
29. Shore RE, Hempelmann L, Kowaluk E: Breast neoplasms in women treated with x-rays for acute post-partum mastitis. J Natl Cancer Inst 59:813-822, 1977
30. Shore RE, Hildreth N, Woodard ED: Breast cancer among women given x-ray therapy for acute post-partum mastitis. J Natl Cancer Inst 77:689-696, 1986
31. Boice JDJ, Blettner M: Radiation dose and breast cancer in patients treated for cancer of the cervix. Int J Cancer 44:7-16, 1989
32. Boice JDJ, Harvey EB, Blettner M: Cancer in the contralateral breast after radiotherapy for breast cancer. N Engl J Med 326:781-785, 1992
33. Thomas DB, Rosenblatt K, Jimenez LM, et al: Ionizing radiation and breast cancer in men (United States). Cancer Causes Control 5:9-14, 1994
34. Colvett KT: Bilateral breast carcinoma after radiation therapy for Hodgkin's disease. South Med J 88:239-242, 1995
35. Prior P, Pope DJ: Hodgkin's disease: Subsequent primary cancers in relation to treatment. Br J Cancer 58:512-517, 1988
36. Yahalom J, Petrek JA, Biddinger PW. et al: Breast cancer in patients irradiated for Hodgkin's disease: A clinical and pathologic analysis of 45 events in 37 patients. J Clin Oncol 10:1674-1681, 1992
37. Hancock SL, Tucker MA, Hoppe RT: Breast cancer after treatment of Hodgkin's disease. J Natl Cancer Inst 85:25-31, 1993
38. O'Brien PC, Baton MB, Fisher R: Breast cancer following treatment for Hodgkin's disease: The need for screening in a young population. Australasian Radiol 39:271-276, 1995
39. Bhatia S, Robison LL, Oberlin O, et al: Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med 334:745-751, 1996
40. van Leeuwen FE, Klokman WJ, Hagenbeek A, et al: Second cancer risk following Hodgkin's disease: A 20-year follow-up study. J Clin Oncol 12:312-325, 1994
41. Carey RW, Linggood RM, Wood W, et al: Breast cancer developing in four women cured of Hodgkin's disease. Cancer 54:2234-2236, 1984
42. Cook KL, Adler DD, Lichter AS, et al: Breast carcinoma in young women previously treated for Hodgkin's disease. AJR 155:39-42, 1990
43. Geffen DB, Krause I, Faermann S, et al: Bilateral synchronous breast carcinoma with axillary node involvement fifteen years after radiotherapy for Hodgkin's disease. Acta Oncol 31:477-478, 1992 (letter)
44. Boice JDJ, Mandel JS, Doody MM: Breast cancer among radiologie technologists. JAMA 274(5): 394-401, 1995
45. Dershaw DD, Yahalom J, Petrek JA: Breast carcinoma in women previously treated for Hodgkin's disease: Mammographic evaluation. Radiology 184:421-423, 1992
46. Abeloff MD, Lichter AS, Niederhuber JE: Management of specific malignancies/III: Breast, in Abeloff MD, Armitage JO, Lichter AS, et al (eds): Clinical Oncology. New York, NY, Churchill Livingstone, 1995, pp 1617-1714
47. Hoffman DA, Lonstein JE, Morin MM: Breast cancer in women with scoliosis exposed to multiple diagnostic x-rays. J Natl Cancer Inst 81:1307-1312, 1989
48. Tokunaga M, Land CE, Yamamoto T: Incidence of female breast cancer among atomic bomb survivors, Hiroshima and Nagasaki, 1950-1980. Radiat Res 112:243-272, 1987
49. Yokoro K, Nakano M, Ito A, Nagano K: Role of prolactin in rat mammary carcinogenesis: Detection of carcinogenicity of low-dose carcinogens and persisting dormant cancer cells. J Natl Cancer Inst 58:1777-1783, 1977
50. Clifton KH, Crowley J: Effects of radiation type and role of glucocorticoids, gonadectomy and thyroidectomy in mammary tumor induction in MtT-grafted rats. Cancer Res 38:1507-1513, 1978
51. Shellabarger CJ: A comparison of rat mammary carcinogenesis following total body irradiation at different ages. Radiat Res 59:103, 1974
52. Yamanouchi H, Ishii-Ohb H, Suzuki K, et al: Relationship between stages of mammary development and sensitivity to gamma-ray irradiation in mammary tumorigenesis in rats. Int J Cancer 60:230-234, 1995
53. Inano H, Suzuki K, Onoda M, et al: Susceptibility of fetal, virgin, pregnant and lactating rats for the induction of mammary tumors by gamma rays. Radiat Res 145:708-713, 1996
54. Kronenberg A: Radiation-induced genomic instability. Int J Radiat Biol 66:603-609, 1994
55. Gorgojo L, Little JB: Expression of lethal mutations in progeny of irradiated mammalian cells, Int J Radiat Biol 55:619-630, 1989
56. Jeggo PA, Kemp LM: X-ray sensitive mutants of Chinese hamster ovary cell line. Isolation and cross-sensitivity to other DNA-damaging agents. Mutat Res 112:313-327, 1983
57. Mihara K, Bai L, Kano Y, et al: Malignant transformation of human fibroblasts previously immortalized with 60Co gamma rays. Int J Cancer 50:639-643, 1992
58. Hall JM, Lee MK, Newman B, et al: Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250:1684-1689, 1983
59. Brown MA, Solomon E: Towards cloning the familial breast-ovarian gene on chromosome 17. Curr Opin Genes Dev 4:439-445, 1994
60. Easton DF, Bishop DT, Ford D, et al: Genetic linkage analysis in familial breast and ovarian cancer: Results from 214 families. Am J Hum Genet 52:678-701, 1993
61. Wooster R, Neuhausen SL, Mangion J, et al: Localization of a breast cancer susceptibility gene BRCA2, to chromosome 13q12-13. Science 265:2088-2090, 1994
62. Hollstein M, Sidransky D, Vogelstein B, et al: p53 mutations in human cancers. Science 253:49-53, 1991
63. Levine AJ, Momand J, Finlay CA: The p53 tumour suppressor gene. Nature 351:453-456, 1991
64. Vogelstein B, Kinzler KW: p53 function and dysfunction. Cell 70:523-526, 1992
65. Gatti RA: Localizing the genes for ataxia telangiectasia: A human model for inherited cancer susceptibility. Cancer Res 56:77-104, 1991
66. Pippard EC, Hall AJ, Barker DJP, et al: Cancer in homozygotes and heterozygotes of ataxia-telangiectasia and xeroderma pigmentosum in Britain. Cancer Res 48:2929-2943, 1988
67. Borresen A, Anderson TI, Tretli S, et al: Breast cancer and other cancers in Norwegian families with ataxia-telangiectasia. Genes Chromosome Cancer 2:339-340, 1990
68. Chakraborty R, Sankaranarayanan K: Cancer predisposition, radiosensitivity and the risk of radiation-induced cancers. II. A Mendelian single-locus model of cancer predisposition and radiosensitivity for predicting cancer risks in populations. Radiat Res 143:293-327, 1995
69. Swift M, Morrell D, Massey RB, et al: Incidence of cancer in 161 families affected by ataxia-telangiectasia. N Engl J Med 325:1831-1836, 1991
70. Lavin MF, Bennett I, Ramsay J, et al: Identification of a potentially radiosensitive subgroup among patients with breast cancer. J Natl Cancer Inst 86:1627-1636, 1994
71. Helzlsouer KJ, Harris EL, Parshad R, et al: Familial clustering of breast cancer: Possible interaction between DNA repair proficiency and radiation exposure in the development of breast cancer. Int J Cancer 64:14-17, 1995
72. Russo J, Russo UH: Hormonally induced differentiation: A novel approach to breast cancer prevention. J Cell Biochem 22:58-64, 1995 (suppl)
73. Spicer DV, Pike MC: The prevention of breast cancer through ovarian steroid exposure. Acta Oncol 31:167-174, 1992
74. Nayfield SG, Karp JE, Ford LG, et al: Potential role of tamoxifen in prevention of breast cancer. J Natl Cancer Inst 83:1450-1459, 1991
75. Shapiro CL, Mauch PM: Radiation-associated breast cancer after Hodgkin's disease: Risks and screening in perspective. J Clin Oncol 10:1662-1665, 1992 (editorial)
76. Early Breast Cancer Trialists' Collaborative Group: Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women. N Engl J Med 319:1681-1692, 1988
77. Stewart HJ for the Scottish Cancer Trials Breast Group: The Scottish Trial of adjuvant tamoxifen in node-negative breast cancer. J Natl Cancer Inst Monogr 11:117-120, 1992
78. Serraino M, Thompson LU: Effect of flaxseed on the initiation andpromotional stages of mammary carcinogenesis. Nutr Cancer 17: 153, 1991
79. Cave WT Jr: Dietary fat effects on animal models of breast cancer. Adv Exp Med Biol 364:47-58, 1994
80. Jeffries DO, Adler DD: Mammographic detection of breast cancer in women under the age of 35. Invest Radiol 25:67-71, 1990
81. Tester WJ, Kinsella TJ, Waller B, et al: Second malignant neoplasms complicating Hodgkin's disease: The National Cancer Institute experience. J Clin Oncol 2:762-769, 1984
82. Kaldor JM, Day NE, Band P, et al: Second malignancies following testicular cancer, ovarian cancer and Hodgkin's disease: An international collaborative study among cancer registries. Int J Cancer 39:571-585, 1987
83. JanJan NA, Wilson JF, Gillin M, et al: Mammary carcinoma developing after radiotherapy and chemotherapy for Hodgkin's disease. Cancer 61:252-254, 1988
84. Anderson N, Lokich J: Bilateral breast cancer after cured Hodgkin's disease. Cancer 65:221-223, 1990
85. Li FP, Corkery J, Canellos G, et al: Breast cancer after Hodgkin's disease in two sisters. Cancer 47:200-202, 1981